Pulse Biosciences, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Pulse Biosciences, Inc. (PLSE) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2023-03-31
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-09-30 was $0.00.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-03-31 was $8.00M, a 40.74% decline year-over-year.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2021 was $8.00M, a 77.14% decline from fiscal 2020.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2020 was $35.00M, a 48.91% decline from fiscal 2019.
- Pulse Biosciences, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2019 was $68.50M, a 63.82% increase from fiscal 2018.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $8.00M 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $8.00M 10-Q · filed 2022-11-10 | $38.49M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $8.00M 10-Q · filed 2022-08-10 | $38.49M derived: sum of 3 quarters · filed 2023-03-31 | $26.00M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $8.00M 10-Q · filed 2022-05-11 | $38.49M derived: sum of 2 quarters · filed 2023-03-31 | $26.00M derived: sum of 3 quarters · filed 2023-03-31 | $29.50M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $30.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $18.00M derived: sum of 2 quarters · filed 2023-03-31 | $21.50M derived: sum of 3 quarters · filed 2023-03-31 | $35.00M 10-K · filed 2023-03-31 |
| 2020-09-30 | -$12.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$8.99M derived: sum of 2 quarters · filed 2021-11-15 | $4.51M 10-Q · filed 2021-11-15 | $16.01M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $17.00M 10-Q · filed 2021-08-09 | $28.50M derived: sum of 3 quarters · filed 2022-03-31 | $53.50M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $13.50M 10-Q · filed 2021-05-10 | $25.00M derived: sum of 2 quarters · filed 2022-03-31 | $50.00M derived: sum of 3 quarters · filed 2022-03-31 | $73.50M derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $36.50M derived: sum of 2 quarters · filed 2022-03-31 | $60.00M derived: sum of 3 quarters · filed 2022-03-31 | $68.50M 10-K · filed 2022-03-31 |
| 2019-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $48.50M derived: sum of 2 quarters · filed 2020-11-09 | $57.00M 10-Q · filed 2020-11-09 | $63.75M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $32.00M 10-Q · filed 2020-08-10 | $38.75M derived: sum of 3 quarters · filed 2021-03-12 | $55.50M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $8.50M 10-Q · filed 2020-05-11 | $15.25M derived: sum of 2 quarters · filed 2021-03-12 | $32.00M derived: sum of 3 quarters · filed 2021-03-12 | $44.00M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $23.50M derived: sum of 2 quarters · filed 2021-03-12 | $35.50M derived: sum of 3 quarters · filed 2021-03-12 | $41.81M 10-K · filed 2021-03-12 |
| 2018-09-30 | $16.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $28.75M derived: sum of 2 quarters · filed 2019-11-07 | $35.06M 10-Q · filed 2019-11-07 | $42.18M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $18.32M 10-Q · filed 2019-08-08 | $25.43M derived: sum of 3 quarters · filed 2020-03-16 | $29.21M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $6.32M 10-Q · filed 2019-05-03 | $13.43M derived: sum of 2 quarters · filed 2020-03-16 | $17.21M derived: sum of 3 quarters · filed 2020-03-16 | $23.66M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $10.90M derived: sum of 2 quarters · filed 2020-03-16 | $17.35M derived: sum of 3 quarters · filed 2020-03-16 | $23.15M 10-K · filed 2020-03-16 |
| 2017-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $10.23M derived: sum of 2 quarters · filed 2018-11-01 | $16.03M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $12.25M 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $5.80M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $4.75M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |